Journal article · 2026 · Open access

Artificial Intelligence in Drug Discovery: Transforming Pharmaceutical Research and Development

Rahul Sunil Padvi

International Journal for Research in Applied Science and Engineering Technology, 14(5), 4549–4556 · Published 22 May 2026 · DOI 10.22214/ijraset.2026.82792

Free PDFCite this paper

In brief

“Artificial Intelligence in Drug Discovery: Transforming Pharmaceutical Research and Development” is a 2026 journal article by Rahul Sunil Padvi, published in International Journal for Research in Applied Science and Engineering Technology. OpenAlex counts 0 citations as of 15 November 2026. It is open access: the full text is free to read at International Journal for Research in Applied Science and Engineering Technology.

Citations
0
Authors
1

Abstract

Artificial Intelligence (AI) has emerged as a transformative force in drug discovery, addressing the limitations of traditional pharmaceutical research methods. Conventional drug development is a lengthy, costly, and high-risk process, often taking more than a decade with significant financial investment. AI technologies, including machine learning, deep learning, and data analytics, enable rapid processing of vast biological and chemical datasets, thereby accelerating the identification of potential drug candidates and improving decision-making throughout the discovery pipeline. AI applications span multiple stages of drug discovery, including target identification, virtual screening, lead optimization, and clinical trial design. By leveraging predictive models and pattern recognition, AI enhances the accuracy of molecular interactions, toxicity prediction, and pharmacokinetic profiling. Furthermore, AI-driven approaches facilitate drug repurposing, reducing development timelines and costs. The integration of AI with bioinformatics and cheminformatics has significantly improved efficiency, productivity, and success rates in pharmaceutical research. Despite its advantages, the implementation of AI in drug discovery faces challenges such as data quality issues, lack of interpretability, and regulatory concerns. However, ongoing advancements in computational power and algorithm development continue to overcome these limitations. AI is expected to play a pivotal role in the future of personalized medicine and precision therapeutics, ultimately revolutionizing the pharmaceutical industry and improving global healthcare outcomes.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Padvi, R. S. (2026). Artificial Intelligence in Drug Discovery: Transforming Pharmaceutical Research and Development. International Journal for Research in Applied Science and Engineering Technology, 14(5), 4549–4556. https://doi.org/10.22214/ijraset.2026.82792

MLA 9

Padvi, Rahul Sunil. “Artificial Intelligence in Drug Discovery: Transforming Pharmaceutical Research and Development.” International Journal for Research in Applied Science and Engineering Technology, vol. 14, no. 5, 2026, pp. 4549–4556. https://doi.org/10.22214/ijraset.2026.82792.

Chicago

Padvi, Rahul Sunil. 2026. “Artificial Intelligence in Drug Discovery: Transforming Pharmaceutical Research and Development.” International Journal for Research in Applied Science and Engineering Technology 14 (5): 4549–4556. https://doi.org/10.22214/ijraset.2026.82792.

Harvard

Padvi, R. S. (2026) ‘Artificial Intelligence in Drug Discovery: Transforming Pharmaceutical Research and Development’, International Journal for Research in Applied Science and Engineering Technology, 14(5), pp. 4549–4556. doi:10.22214/ijraset.2026.82792.

IEEE

R. S. Padvi, “Artificial Intelligence in Drug Discovery: Transforming Pharmaceutical Research and Development,” International Journal for Research in Applied Science and Engineering Technology, vol. 14, no. 5, pp. 4549–4556, 2026, doi: 10.22214/ijraset.2026.82792.

BibTeX

@article{padvi2026artificial,
  title     = {{Artificial Intelligence in Drug Discovery: Transforming Pharmaceutical Research and Development}},
  author    = {Padvi, Rahul Sunil},
  journal   = {International Journal for Research in Applied Science and Engineering Technology},
  year      = {2026},
  volume    = {14},
  number    = {5},
  pages     = {4549--4556},
  doi       = {10.22214/ijraset.2026.82792},
  url       = {https://doi.org/10.22214/ijraset.2026.82792}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • artificial intelligence in drug discovery
  • machine learning
  • deep learning
  • virtual screening
  • lead optimization
  • target identification
  • clinical trial design
  • toxicity prediction

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Padvi, R. S. (2026). Artificial Intelligence in Drug Discovery: Transforming Pharmaceutical Research and Development. International Journal for Research in Applied Science and Engineering Technology, 14(5), 4549–4556. https://doi.org/10.22214/ijraset.2026.82792

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at International Journal for Research in Applied Science and Engineering Technology.

Who wrote this paper?

Rahul Sunil Padvi.

What is the DOI of this paper?

10.22214/ijraset.2026.82792. The permanent link is https://doi.org/10.22214/ijraset.2026.82792.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.